What is the best medication for menstrual-related migraines?

Best Medication for Menstrual-Related Migraines

For acute treatment of menstrual migraines, use triptans—specifically frovatriptan or naratriptan—as first-line therapy, and for perimenstrual prophylaxis when acute treatment fails, use frovatriptan 2.5 mg twice daily or naproxen starting 2 days before expected menstruation for 5 days.

Acute Treatment Approach

First-Line: Long-Acting Triptans

For menstrual migraines that require acute treatment, triptans are superior to NSAIDs and other analgesics 1. However, not all triptans are equal for menstrual migraine:

• Frovatriptan has a 26-hour half-life, providing longer duration of action and significantly lower relapse rates compared to other triptans (24-hour sustained pain-free: RR 0.34) 2
• Naratriptan is also recommended due to its longer half-life 1
• Sumatriptan (particularly subcutaneous) provides superior pain relief at 2 hours (OR: 4.62) and 24 hours (OR: 4.81) 3

Clinical pearl: Menstrual migraines are typically longer, more severe, and more likely to relapse than non-menstrual attacks 2. The longer half-life of frovatriptan and naratriptan specifically addresses the relapse problem.

Combination Therapy Option

Sumatriptan-naproxen combination provides dual benefits: migraine relief plus relief of dysmenorrhea symptoms (bloating, fatigue, irritability, abdominal/back pain) 4. This is particularly valuable since ~60% of menstrual migraineurs have concurrent dysmenorrhea.

Perimenstrual Prophylaxis (Short-Term Prevention)

When optimized acute treatment doesn't suffice—which is common since menstrual attacks are "less responsive to treatment" 2—initiate perimenstrual preventive treatment 1:

Recommended Regimens:

1. Frovatriptan 2.5 mg twice daily for 6 days (starting 2 days before expected menstruation)

   • Most effective dosing: twice daily superior to once daily (RR 1.27) 2
   • Significantly reduces risk of menstrual migraine (RR 1.98 for twice daily vs placebo) 2

2. Naproxen (long-acting NSAID) daily for 5 days, beginning 2 days before expected first day of menstruation 1

3. Alternative triptans: Naratriptan can also be used in similar perimenstrual prophylaxis protocols 1

When to Use Continuous Prevention

For women with pure menstrual migraine without aura, consider continuous use of combined hormonal contraceptives 1.

Critical contraindication: Combined hormonal contraceptives are absolutely contraindicated in women with migraine with aura due to increased stroke risk 1.

If menstrual cycles are irregular or perimenstrual prophylaxis fails, use standard continuous migraine prevention:

• First-line: Beta-blockers (propranolol 80-160 mg daily), topiramate (50-100 mg daily), or candesartan (16-32 mg daily) 1
• Note: Sodium valproate is absolutely contraindicated in women of childbearing potential 1

Newer Options (When Available)

CGRP monoclonal antibodies (erenumab, galcanezumab) show superior efficacy in reducing monthly headache days compared to triptans 3, but cost considerations typically place these as second-line options 5.

Common Pitfalls to Avoid

1. Don't use short-acting triptans (like standard sumatriptan oral) for perimenstrual prophylaxis—the longer half-life of frovatriptan/naratriptan is specifically advantageous 2

2. Don't prescribe valproate to women of childbearing potential—it's teratogenic 1

3. Don't give combined hormonal contraceptives to women with migraine with aura—stroke risk 1

4. Don't undertreat: Menstrual migraines are inherently more difficult to treat; if acute therapy alone isn't working after 2-3 cycles, move to perimenstrual prophylaxis rather than continuing inadequate treatment 1